JPMorgan Chase: How much flexibility should a $50 billion buyback authorization preserve?
Download case PDF (5 pages)Request teacher’s pack
Decision case | Information cutoff: 3 October 2026, 11:59 p.m. ET
On June 24, 2026, JPMorgan Chase’s board authorized a new common-share repurchase program of up to $50 billion, effective July 1. The company said management would determine the amount and timing; the authorization did not require the company to buy shares on a set schedule. [P5, P9] By October 3, the bank had reported its second-quarter results, declared a higher quarterly dividend, and described significant technology and branch investment. [P3, P6, P4, P7] The next quarterly results were scheduled for October 13, after the decision cutoff. [P8]
The question is not whether a board authorization exists. It does. The strategic question is how management should pace that discretion through a classroom decision horizon running through 2027, while balancing shareholder distributions, investment, and the capital and liquidity requirements of a large bank. “Through 2027” is the case horizon; it is not a disclosed expiry date for the authorization or a management repurchase plan.
A strong quarter, with important qualifications
For the second quarter of 2026, JPMorgan reported net income of $21.2 billion, a $4.0 billion common dividend, and $6.2 billion of common-share net repurchases. The reported quarter also included a $4.6 billion gain related to Visa shares and $1.0 billion in gains on certain equity investments. Management separately presented $16.9 billion of net income excluding significant items. That is an issuer-defined non-GAAP measure, not the reported GAAP figure. [P3]
The $6.2 billion figure is net common-stock repurchases and includes the net impact of employee share issuances. The separate Q2 earnings supplement reports 21.7 million shares repurchased at an aggregate gross purchase price of $6.703 billion, excluding excise taxes and commissions. Both figures describe Q2 activity, which ended before the refreshed program took effect on July 1. [P3, P9]
JPMorgan also reported a 73% trailing-twelve-month net payout ratio. The figure combines repurchases and dividends under the issuer’s definition; it is a historical ratio, not a target for the new authorization. On September 15, the board declared a quarterly dividend of $1.65 per share, up from $1.50, payable October 31. At the case cutoff it had been declared but not yet paid. [P3, P6]
Capital is not the same as cash
The Q2 Form 10-Q, filed in August, reported $303 billion of Common Equity Tier 1 capital and a 14.2% Standardized CET1 ratio at June 30. The current Standardized requirement including regulatory buffers was 11.5%. Subtracting the latter from the former ratio gives a 2.7 percentage-point spread. That arithmetic does not show how many dollars JPMorgan can distribute: regulatory capital, risk-weighted assets, other capital constraints, liquidity, subsidiary rules, and management’s internal buffers all matter. [P2]
The July earnings release had reported the Standardized ratio as 14.1%, while the later-filed 10-Q showed 14.2% for both Standardized and Advanced CET1. The filed 10-Q is the current source for the case’s June 30 ratio. No inference about an unrounded ratio is available. [P2, P3]
The company’s 2.5% stress capital buffer remained in effect through September 30, 2027; supervisory capital requirements were due for recalculation in 2027. The 10-Q also described a proposed capital-rule change and JPMorgan’s estimate that, applied to year-end 2025 positions, the proposal could increase required CET1 capital by about 6%. The proposal was not final at the cutoff, and the 6% estimate is not a six-percentage-point change in the CET1 ratio. [P2, P5]
Liquidity measures add context, but they are not a buyback budget either. At June 30 the company reported approximately $1.5 trillion in liquidity sources, composed of about $956 billion of eligible high-quality liquid assets and $541 billion of unencumbered marketable securities. Average Firm liquidity coverage ratio was 110% in Q2, down from 112% in Q1. JPMorgan attributed the decline partly to common-stock repurchases and dividends and partly to Markets liquidity use, among other offsets. That quarterly movement does not establish that repurchases alone caused a binding constraint. [P2, P3]
Other uses of capital and operating capacity
JPMorgan’s February 2026 Company Update showed a capital-allocation framework spanning growth of businesses and organic opportunities, dividends, price-dependent buybacks, and preparation for macroeconomic or regulatory change. It also described a significant buffer alongside investment and distributions. This was management’s framework and retrospective illustration, not a promised future allocation schedule. [P4]
Management estimated technology expense of about $19.8 billion for 2026, up 10% year over year, and described roughly $1.2 billion of additional spend on major projects. Its adjusted-expense outlook for 2026 was approximately $107.5 billion and market-dependent. Adjusted expense is non-GAAP. The public materials do not disclose individual technology project costs, returns, or the amount already committed versus controllable. These estimates should not be read as a fungible pool that could be redirected dollar for dollar to repurchases. [P2, P4]
Physical expansion was also under way. JPMorgan announced plans for more than 160 branch openings in over 30 states and nearly 600 renovations during 2026, as part of a three-year plan for over 500 branches, 1,700 renovations, and 3,500 hires. The announcement provided no site-level return, cost, or 2027 target. [P7]
The repurchase authorization was expressly discretionary. The 10-Q said the company had no specific price target or timetable and could suspend the program. It listed market conditions, legal and regulatory constraints, capital position, organic capital generation, future capital requirements, and alternative investment opportunities among the factors management considers. [P2, P5]
The choice
Assume you are preparing a recommendation for a hypothetical capital-allocation review. You have no access to internal capital plans, stress scenarios, intrinsic-value analysis, or project returns. The alternatives below are classroom choices, not disclosed JPMorgan proposals:
- Continue a material, price-sensitive pace of repurchases when capital planning and stress scenarios support it.
- Slow or pause repurchases at review gates, preserving more capital through regulatory and business uncertainty while continuing the declared dividend and funding high-priority investment.
Prepare a recommendation for how the company should govern the authorization over the case horizon. Identify the evidence and triggers you would require before accelerating, maintaining, slowing, or suspending purchases. Explain how the same evidence could support a different recommendation. Do not convert the 2.7-point ratio spread into distributable dollars or assume the authorization is a commitment.
Exhibit 1. Distribution and earnings context
| Q2 2026 reported item | Amount / measure | Definition and timing |
|---|---|---|
| Net income | $21.2bn | Reported GAAP net income; exact statement amount $21.155bn |
| Visa-related gain | $4.6bn | Included in the reported quarter |
| Certain equity-investment gains | $1.0bn | Included in the reported quarter |
| Net income excluding significant items | $16.9bn | Management non-GAAP presentation |
| Common dividends | $4.0bn | Q2 total; $1.50/share then |
| Common-stock net repurchases | $6.2bn | Net of employee issuances; Q2 activity |
| Gross purchase price | $6.703bn | Separate supplement measure; before employee issuances, excludes taxes/commissions |
| LTM net payout | 73% | Historical trailing-twelve-month ratio; not guidance |
Sources: Q2 earnings release P3, printed pp.1–2, 6–7; Q2 supplement P9, printed p.11. The repurchases occurred before the new authorization became effective.
Exhibit 2. June 30, 2026 capital and liquidity snapshot
| Measure | Reported value | Interpretation |
|---|---|---|
| CET1 capital | $303bn | Regulatory capital amount |
| Standardized CET1 ratio | 14.2% | Filed 10-Q value |
| Standardized CET1 requirement incl. buffers | 11.5% | Current requirement |
| Derived ratio difference | 2.7 percentage points | Ratio subtraction only; not available dollars |
| Stress capital buffer | 2.5% | In effect through 30 Sep 2027 |
| Average Firm LCR, Q2 | 110% | Versus 112% in Q1 |
| Liquidity sources | About $1.5tn | $956bn eligible HQLA plus $541bn unencumbered marketable securities |
Source: Q2 2026 Form 10-Q P2, printed pp.5–6 and 44–58; company release P5. Regulatory capital ratios, LCR and liquidity-source aggregates are different measures.
Exhibit 3. Disclosed investment context
| Public statement | Amount / scope | Evidence limit |
|---|---|---|
| 2026 technology expense estimate | About $19.8bn, up 10% YoY | Management estimate; no project-level ROI or 2027 budget |
| Additional major-project spend | Roughly $1.2bn | Management description; commitments and timing not itemized |
| 2026 adjusted-expense outlook | About $107.5bn | Non-GAAP, market-dependent guidance |
| 2026 branch plan | >160 openings; nearly 600 renovations | No site-level cost, return or 2027 target |
Sources: Company Update P4, slide 12 and transcript pp.3–4; Q2 10-Q P2, pp.18–19; branch announcement P7.
Source key
- P2 — Q2 2026 Form 10-Q, filed 6 August 2026.
- P3 — Q2 2026 earnings release, Exhibit 99.1, 14 July 2026.
- P4 — 2026 Company Update, filed presentation, 23 February 2026.
- P5 — new repurchase authorization and dividend announcement, 24 June 2026.
- P6 — declared $1.65 quarterly dividend, 15 September 2026.
- P7 — 2026 branch-opening and renovation plan, 18 February 2026.
- P8 — Q3 earnings scheduled for 13 October, 17 September 2026.
- P9 — Q2 2026 Earnings Supplement, Exhibit 99.2, 14 July 2026.